No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1v54U, 1.0000, 0.00, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
2, 2dyrU, 0.9998, 0.04, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
3, 1v54H, 0.9998, 0.04, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
4, 2dyrH, 0.9996, 0.06, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
5, 2eikU, 0.9994, 0.07, 1.000, 79, 79, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
6, 2eijU, 0.9994, 0.08, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
7, 2eikH, 0.9993, 0.08, 1.000, 79, 79, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
8, 2eijH, 0.9992, 0.08, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
9, 2eilU, 0.9991, 0.09, 1.000, 79, 79, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
10, 2eilH, 0.9990, 0.09, 1.000, 79, 79, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
11, 1v55U, 0.9990, 0.10, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
12, 3asoU, 0.9989, 0.10, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
13, 3asnU, 0.9988, 0.11, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
14, 1v55H, 0.9988, 0.11, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
15, 3asoH, 0.9984, 0.12, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
16, 3asnH, 0.9983, 0.13, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
17, 2eimU, 0.9980, 0.14, 1.000, 79, 79, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
18, 2eimH, 0.9980, 0.14, 1.000, 79, 79, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
19, 2dysH, 0.9973, 0.16, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
20, 2dysU, 0.9972, 0.17, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
21, 3ag2H, 0.9970, 0.17, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
22, 3ag2U, 0.9967, 0.18, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
23, 3ag4H, 0.9965, 0.19, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
24, 3ag4U, 0.9964, 0.19, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
25, 2einU, 0.9963, 0.19, 1.000, 79, 79, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
26, 2einH, 0.9962, 0.19, 1.000, 79, 79, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
27, 3ag3U, 0.9951, 0.22, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
28, 3ag1U, 0.9947, 0.23, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
29, 3abkU, 0.9934, 0.26, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
30, 5b1bU, 0.9932, 0.27, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
31, 3ag1H, 0.9929, 0.27, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
32, 3wg7U, 0.9925, 0.28, 1.000, 79, 79, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
33, 3ag3H, 0.9924, 0.29, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
34, 5b1aU, 0.9908, 0.32, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
35, 3x2qU, 0.9880, 0.37, 1.000, 79, 79, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
36, 5b1bH, 0.9863, 0.42, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
37, 3x2qH, 0.9863, 0.39, 1.000, 79, 79, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
38, 5b3sH, 0.9861, 0.43, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
39, 3abkH, 0.9855, 0.43, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
40, 3wg7H, 0.9837, 0.47, 1.000, 79, 79, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
41, 5b1aH, 0.9834, 0.47, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
42, 5wauh, 0.9830, 0.44, 1.000, 79, 79, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
43, 5wauH, 0.9810, 0.59, 1.000, 79, 79, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
44, 5x19U, 0.9775, 0.56, 1.000, 79, 79, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
45, 5w97h, 0.9771, 0.55, 1.000, 79, 79, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
46, 5b3sU, 0.9758, 0.58, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
47, 5xdqU, 0.9748, 0.61, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
48, 5xdqH, 0.9747, 0.60, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
49, 5x1fH, 0.9744, 0.38, 0.974, 79, 78, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
50, 1ocrU, 0.9737, 0.39, 0.974, 79, 78, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
51, 1ocrH, 0.9736, 0.39, 0.974, 79, 78, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
52, 5x1bU, 0.9714, 0.71, 1.000, 79, 79, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
53, 5iy5H, 0.9714, 0.59, 1.000, 79, 79, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
54, 5x1fU, 0.9708, 0.75, 1.000, 79, 79, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
55, 5w97H, 0.9699, 0.62, 1.000, 79, 79, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
56, 5x1bH, 0.9697, 0.67, 1.000, 79, 79, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
57, 5x19H, 0.9696, 0.74, 1.000, 79, 79, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
58, 5xdxU, 0.9695, 0.64, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
59, 5xdxH, 0.9685, 0.72, 1.000, 79, 79, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
60, 2occU, 0.9656, 0.55, 0.974, 79, 78, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
61, 2occH, 0.9655, 0.55, 0.974, 79, 78, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
62, 5iy5U, 0.9570, 0.92, 1.000, 79, 79, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
63, 3abmU, 0.9455, 0.20, 1.000, 75, 75, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
64, 2zxwU, 0.9443, 0.23, 1.000, 75, 75, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
65, 2y69U, 0.9441, 0.24, 1.000, 75, 75, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
66, 3abmH, 0.9435, 0.25, 1.000, 75, 75, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
67, 2zxwH, 0.9435, 0.25, 1.000, 75, 75, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
68, 2y69H, 0.9419, 0.29, 1.000, 75, 75, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
69, 3ablH, 0.9400, 0.32, 1.000, 75, 75, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
70, 3ablU, 0.9365, 0.37, 1.000, 75, 75, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
71, 5xtiCE, 0.9060, 0.75, 0.959, 75, 74, struct.pdbx_descriptor              
72, 5xtiAB, 0.9060, 0.75, 0.959, 75, 74, struct.pdbx_descriptor              
73, 5xthAB, 0.9060, 0.75, 0.959, 75, 74, struct.pdbx_descriptor              
74, 5luf5, 0.9060, 0.75, 0.959, 75, 74, CRYO-EM OF BOVINE RESPIRASOME
75, 5gupBC, 0.9060, 0.75, 0.959, 75, 74, 
76, 5gpnBB, 0.9060, 0.75, 0.959, 75, 74, 
77, 2ybbS, 0.9060, 0.75, 0.959, 75, 74, FITTED MODEL FOR BOVINE  MITOCHONDRIAL SUPERCOMPLEX I1III2IV1 BY SINGLE PARTICLE CRYO-EM (EMD-1876)
78, 1occU, 0.9060, 0.75, 0.959, 75, 74, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
79, 1occH, 0.9060, 0.75, 0.959, 75, 74, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
80, 1ocoU, 0.9049, 0.75, 0.959, 75, 74, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
81, 1ocoH, 0.9048, 0.75, 0.959, 75, 74, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
82, 1oczH, 0.8983, 0.83, 0.959, 75, 74, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
83, 1oczU, 0.8982, 0.83, 0.959, 75, 74, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
84, 5j7yFC, 0.8460, 1.43, 1.000, 79, 79, 
85, 5j4zFC, 0.8460, 1.43, 1.000, 79, 79, 
86, 4ps3A, 0.6348, 3.09, 0.027, 843, 74, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH 1-[6-(5-METHOXYPYRIDIN-3-YL)- 13-BENZOTHIAZOL-2-YL]-3-[2-(1-PROPYL-1H-IMIDAZOL-4-YL)ETHYL]UREA
87, 3oawA, 0.6315, 3.12, 0.027, 841, 74, 4-METHYLPTERIDINEONES AS ORALLY ACTIVE AND SELECTIVE PI3K/MTOR DUAL INHIBITORS
88, 6gq7A, 0.6313, 3.13, 0.027, 802, 74, PI3KG IN COMPLEX WITH INH 
89, 4ps7A, 0.6312, 3.12, 0.027, 843, 74, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH N-[6-(PYRIDIN-3-YL)-13- BENZOTHIAZOL-2-YL]ACETAMIDE
90, 4ps8A, 0.6310, 3.10, 0.027, 843, 74, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH N-[6-(56-DIMETHOXYPYRIDIN-3- YL)-13-BENZOTHIAZOL-2-YL]ACETAMIDE
91, 2v4lA, 0.6309, 3.10, 0.027, 844, 74, COMPLEX OF HUMAN PHOSPHOINOSITIDE 3-KINASE CATALYTIC SUBUNIT GAMMA (P110 GAMMA) WITH PIK-284
92, 3l16A, 0.6304, 3.12, 0.027, 841, 74, DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT SELECTIVE AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3- KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER
93, 4j6iA, 0.6301, 3.10, 0.027, 833, 74, DISCOVERY OF THIAZOLOBENZOXEPIN PI3-KINASE INHIBITORS THAT SPARE THE PI3-KINASE BETA ISOFORM
94, 4fhjA, 0.6300, 3.12, 0.027, 819, 74, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDINE 2
95, 5g55A, 0.6297, 3.14, 0.027, 847, 74, 3-QUINOLINE CARBOXAMIDES INHIBITORS OF PI3K
96, 4xz4A, 0.6292, 3.13, 0.027, 843, 74, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH AN INHIBITOR
97, 1e8zA, 0.6292, 3.13, 0.027, 839, 74, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
98, 5oq4A, 0.6288, 3.20, 0.027, 834, 74, PQR309 - A POTENT BRAIN-PENETRANT ORALLY BIOAVAILABLE PAN-CLASS I PI3K/MTOR INHIBITOR AS CLINICAL CANDIDATE IN ONCOLOGY
99, 3ml9A, 0.6288, 3.10, 0.027, 847, 74, DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN
100, 4ezkA, 0.6285, 3.15, 0.027, 842, 74, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
101, 4ezjA, 0.6283, 3.22, 0.027, 834, 74, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
102, 3qjzA, 0.6281, 3.11, 0.027, 795, 74, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH BENZOTHIAZOLE 1
103, 4fulA, 0.6276, 3.14, 0.027, 832, 74, PI3 KINASE GAMMA BOUND TO A PYRMIDINE INHIBITOR
104, 6audA, 0.6274, 3.12, 0.027, 840, 74, PI3K-GAMMA K802T IN COMPLEX WITH CPD 8 10-((1-(TERT-BUTYL)PIPERIDIN-4- YL)SULFINYL)-2-(1-ISOPROPYL-1H-124-TRIAZOL-5-YL)-56- DIHYDROBENZO[F]IMIDAZO[12-D][14]OXAZEPINE
105, 4gb9A, 0.6274, 3.13, 0.027, 840, 74, POTENT AND HIGHLY SELECTIVE BENZIMIDAZOLE INHIBITORS OF PI3K-DELTA
106, 4ezlA, 0.6274, 3.12, 0.027, 834, 74, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
107, 3sd5A, 0.6274, 3.09, 0.027, 817, 74, CRYSTAL STRUCTURE OF PI3K GAMMA WITH 5-(24-DIMORPHOLINOPYRIMIDIN-6- YL)-4-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE
108, 4fhkA, 0.6272, 3.13, 0.027, 819, 74, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDAZINE 19E
109, 3qaqA, 0.6261, 3.15, 0.027, 837, 74, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 2 1
110, 1e8yA, 0.6257, 3.12, 0.027, 841, 74, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
111, 3tl5A, 0.6252, 3.13, 0.027, 845, 74, DISCOVERY OF GDC-0980: A POTENT SELECTIVE AND ORALLY AVAILABLE CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K)/MAMMALIAN TARGET OF RAPAMYCIN (MTOR) KINASE INHIBITOR FOR THE TREATMENT OF CANCER
112, 4aofA, 0.6250, 3.14, 0.027, 836, 74, SELECTIVE SMALL MOLECULE INHIBITOR DISCOVERED BY CHEMOPROTEOMIC ASSAY PLATFORM REVEALS REGULATION OF TH17 CELL DIFFERENTIATION BY PI3KGAMMA
113, 1e8xA, 0.6249, 3.20, 0.027, 841, 74, STRUCTURAL INSIGHTS INTO PHOSHOINOSITIDE 3-KINASE ENZYMATIC MECHANISM AND SIGNALLING
114, 5jhbA, 0.6248, 3.10, 0.027, 811, 74, STRUCTURE OF PHOSPHOINOSITIDE 3-KINASE GAMMA (PI3K) BOUND TO THE POTENT INHIBITOR PIKIN3
115, 4g11A, 0.6240, 3.12, 0.027, 836, 74, X-RAY STRUCTURE OF PI3K-GAMMA BOUND TO A 4-(MORPHOLIN-4-YL)- (6-OXO-1 6-DIHYDROPYRIMIDIN-2-YL)AMIDE INHIBITOR
116, 1e7vA, 0.6212, 3.15, 0.027, 850, 74, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
117, 3bh1D, 0.6210, 3.12, 0.056, 487, 71, CRYSTAL STRUCTURE OF PROTEIN DIP2346 FROM CORYNEBACTERIUM DIPHTHERIAE
118, 3bh1C, 0.6208, 3.12, 0.056, 483, 71, CRYSTAL STRUCTURE OF PROTEIN DIP2346 FROM CORYNEBACTERIUM DIPHTHERIAE
119, 3bh1A, 0.6191, 3.11, 0.056, 486, 71, CRYSTAL STRUCTURE OF PROTEIN DIP2346 FROM CORYNEBACTERIUM DIPHTHERIAE
120, 3bh1B, 0.6182, 3.10, 0.056, 486, 71, CRYSTAL STRUCTURE OF PROTEIN DIP2346 FROM CORYNEBACTERIUM DIPHTHERIAE
121, 4uwkA, 0.6104, 3.28, 0.095, 544, 74, DISCOVERY OF (2S)-8-((3R)-3-METHYLMORPHOLIN-4-YL)-1-(3- METHYL-2-OXO-BUTYL)-2-(TRIFLUOROMETHYL)-34-DIHYDRO-2H- PYRIMIDO(12-A)PYRIMIDIN-6-ONE: A NOVEL POTENT AND SELECTIVE INHIBITOR OF VPS34 FOR THE TREATMENT OF SOLID TUMORS
122, 4uwgA, 0.6093, 3.29, 0.095, 544, 74, DISCOVERY OF (2S)-8-((3R)-3-METHYLMORPHOLIN-4-YL)-1-(3- METHYL-2-OXO-BUTYL)-2-(TRIFLUOROMETHYL)-34-DIHYDRO-2H- PYRIMIDO(12-A)PYRIMIDIN-6-ONE: A NOVEL POTENT AND SELECTIVE INHIBITOR OF VPS34 FOR THE TREATMENT OF SOLID TUMORS
123, 4uwhA, 0.6063, 3.28, 0.095, 554, 74, DISCOVERY OF (2S)-8-((3R)-3-METHYLMORPHOLIN-4-YL)-1-(3- METHYL-2-OXO-BUTYL)-2-(TRIFLUOROMETHYL)-34-DIHYDRO-2H- PYRIMIDO(12-A)PYRIMIDIN-6-ONE: A NOVEL POTENT AND SELECTIVE INHIBITOR OF VPS34 FOR THE TREATMENT OF SOLID TUMORS
124, 4uwlA, 0.6057, 3.09, 0.082, 543, 73, DISCOVERY OF (2S)-8-((3R)-3-METHYLMORPHOLIN-4-YL)-1-(3- METHYL-2-OXO-BUTYL)-2-(TRIFLUOROMETHYL)-34-DIHYDRO-2H- PYRIMIDO(12-A)PYRIMIDIN-6-ONE: A NOVEL POTENT AND SELECTIVE INHIBITOR OF VPS34 FOR THE TREATMENT OF SOLID TUMORS
125, 6eznF, 0.6040, 3.25, 0.043, 650, 70, CRYO-EM STRUCTURE OF THE YEAST OLIGOSACCHARYLTRANSFERASE (OST) COMPLEX
126, 3ihyC, 0.6038, 3.26, 0.095, 537, 74, HUMAN PIK3C3 CRYSTAL STRUCTURE
127, 4oysA, 0.6033, 3.24, 0.108, 553, 74, CRYSTAL STRUCTURE OF VPS34 IN COMPLEX WITH SAR405.
128, 5ennA, 0.6016, 3.40, 0.107, 526, 75, THE CRYSTAL STRUCTURE OF HUMAN VPS34 IN COMPLEX WITH A SELECTIVE AND POTENT INHIBITOR
129, 4tv3A, 0.6008, 3.22, 0.042, 879, 72, ISOLATED P110A SUBUNIT OF PI3KA PROVIDES A PLATFORM FOR STRUCTURE- BASED DRUG DESIGN
130, 5ennB, 0.6004, 3.28, 0.108, 531, 74, THE CRYSTAL STRUCTURE OF HUMAN VPS34 IN COMPLEX WITH A SELECTIVE AND POTENT INHIBITOR
131, 4uwfA, 0.6003, 3.30, 0.095, 550, 74, DISCOVERY OF (2S)-8-((3R)-3-METHYLMORPHOLIN-4-YL)-1-(3- METHYL-2-OXO-BUTYL)-2-(TRIFLUOROMETHYL)-34-DIHYDRO-2H- PYRIMIDO(12-A)PYRIMIDIN-6-ONE: A NOVEL POTENT AND SELECTIVE INHIBITOR OF VPS34 FOR THE TREATMENT OF SOLID TUMORS
132, 1ng6A, 0.6002, 3.20, 0.072, 148, 69, STRUCTURE OF CYTOSOLIC PROTEIN OF UNKNOWN FUNCTION YQEY FROM BACILLUS SUBTILIS
133, 3ihyB, 0.5994, 3.17, 0.110, 535, 73, HUMAN PIK3C3 CRYSTAL STRUCTURE
134, 3ls8A, 0.5993, 3.15, 0.096, 547, 73, CRYSTAL STRUCTURE OF HUMAN PIK3C3 IN COMPLEX WITH 3-[4-(4- MORPHOLINYL)THIENO[32-D]PYRIMIDIN-2-YL]-PHENOL
135, 6ftjCB, 0.5992, 2.89, 0.070, 644, 71, Cryo-EM Structure of the Mammalian Oligosaccharyltransferase Bound to Sec61 and the Non-programmed 80S Ribosome  
136, 6ftiDB, 0.5992, 2.89, 0.070, 644, 71, Cryo-EM Structure of the Mammalian Oligosaccharyltransferase Bound to Sec61 and the Programmed 80S Ribosome  
137, 6ftgCB, 0.5992, 2.89, 0.070, 644, 71, Subtomogram average of OST-containing ribosome-translocon complexes from canine rough microsomal membranes  
138, 5anlA, 0.5990, 3.32, 0.108, 543, 74, CRYSTAL STRUCTURE OF VPS34 IN COMPLEX WITH (2S)-8-((3R)-3- METHYLMORPHOLIN-4-YL)-1-(3-METHYL-2-OXO- BUTYL)-2-( TRIFLUOROMETHYL)-34-DIHYDRO-2H-PYRIMIDO(12-A)PYRIMIDIN-6- ONE PROCESSED WITH THE CRYSTALDIRECT AUTOMATED MOUNTING AND CRYO-COOLING TECHNOLOGY
139, 4ph4B, 0.5988, 3.39, 0.107, 529, 75, THE CRYSTAL STRUCTURE OF HUMAN VPS34 IN COMPLEX WITH PIK-III
140, 3ihyD, 0.5988, 3.19, 0.096, 531, 73, HUMAN PIK3C3 CRYSTAL STRUCTURE
141, 4ovuA, 0.5986, 3.24, 0.041, 1044, 73, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH NISH2 OF P85ALPHA
142, 4tuuA, 0.5985, 3.22, 0.041, 879, 73, ISOLATED P110A SUBUNIT OF PI3KA PROVIDES A PLATFORM FOR STRUCTURE- BASED DRUG DESIGN
143, 5uk8A, 0.5980, 3.26, 0.042, 1008, 72, THE CO-STRUCTURE OF (R)-4-(6-(1-(CYCLOPROPYLSULFONYL)CYCLOPROPYL)-2- (1H-INDOL-4-YL)PYRIMIDIN-4-YL)-3-METHYLMORPHOLINE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
144, 4n83H, 0.5977, 2.83, 0.042, 283, 71, X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS SANGUINIS DIMANGANESE(II)- NRDF
145, 3ls8B, 0.5977, 3.31, 0.108, 522, 74, CRYSTAL STRUCTURE OF HUMAN PIK3C3 IN COMPLEX WITH 3-[4-(4- MORPHOLINYL)THIENO[32-D]PYRIMIDIN-2-YL]-PHENOL
146, 3hizA, 0.5972, 3.27, 0.042, 1024, 72, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA
147, 5f15A, 0.5969, 3.06, 0.055, 541, 73, CRYSTAL STRUCTURE OF ARNT FROM CUPRIAVIDUS METALLIDURANS BOUND TO UNDECAPRENYL PHOSPHATE
148, 6c26A, 0.5956, 3.58, 0.042, 648, 72, THE CRYO-EM STRUCTURE OF A EUKARYOTIC OLIGOSACCHARYL TRANSFERASE COMPLEX
149, 4jpsA, 0.5956, 3.29, 0.041, 999, 73, CO-CRYSTAL STRUCTURES OF THE LIPID KINASE PI3K ALPHA WITH PAN AND ISOFORM SELECTIVE INHIBITORS
150, 3nzuA, 0.5956, 3.02, 0.028, 822, 72, STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE
151, 5ezmA, 0.5948, 3.07, 0.055, 537, 73, CRYSTAL STRUCTURE OF ARNT FROM CUPRIAVIDUS METALLIDURANS IN THE APO STATE
152, 4zopA, 0.5946, 3.30, 0.041, 1000, 73, CO-CRYSTAL STRUCTURE OF LIPID KINASE PI3K ALPHA WITH A SELECTIVE PHOSPHATIDYLINOSITOL-3 KINASE ALPHA INHIBITOR
153, 3ihyA, 0.5946, 3.22, 0.110, 536, 73, HUMAN PIK3C3 CRYSTAL STRUCTURE
154, 4l1bA, 0.5939, 3.23, 0.041, 994, 73, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA
155, 5h9dC, 0.5927, 2.84, 0.045, 188, 66, CRYSTAL STRUCTURE OF HEPTAPRENYL DIPHOSPHATE SYNTHASE FROM STAPHYLOCOCCUS AUREUS
156, 5h9dD, 0.5926, 2.84, 0.045, 188, 66, CRYSTAL STRUCTURE OF HEPTAPRENYL DIPHOSPHATE SYNTHASE FROM STAPHYLOCOCCUS AUREUS
157, 3mjoB, 0.5926, 3.08, 0.070, 296, 71, SMALL SUBUNIT (R2F) OF NATIVE RIBONUCLEOTIDE REDUCTASE FROM CORYNEBACTERIUM AMMONIAGENES
158, 3mjoA, 0.5914, 3.08, 0.070, 296, 71, SMALL SUBUNIT (R2F) OF NATIVE RIBONUCLEOTIDE REDUCTASE FROM CORYNEBACTERIUM AMMONIAGENES
159, 1kgoA, 0.5904, 3.08, 0.070, 296, 71, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS REDUCED FE CONTAINING FORM
160, 1kgoC, 0.5885, 2.99, 0.056, 296, 72, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS REDUCED FE CONTAINING FORM
161, 2x6kA, 0.5880, 3.28, 0.055, 550, 73, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34 IN COMPLEX WITH PI-103
162, 3wajA, 0.5878, 3.13, 0.028, 793, 71, CRYSTAL STRUCTURE OF THE ARCHAEOGLOBUS FULGIDUS OLIGOSACCHARYLTRANSFERASE (O29867_ARCFU) COMPLEX WITH ZN AND SULFATE
163, 1kgnC, 0.5864, 2.91, 0.056, 296, 71, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS OXIDISED FE CONTAINING FORM
164, 1kgpC, 0.5862, 2.99, 0.056, 296, 72, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS MN SUBSTITUTED FORM
165, 4n83G, 0.5857, 2.94, 0.069, 283, 72, X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS SANGUINIS DIMANGANESE(II)- NRDF
166, 1oquC, 0.5853, 3.09, 0.069, 302, 72, A PROTEIN COORDINATED TRI-NUCLEAR FE COMPLEX FORMED DURING SOAKING OF CRYSTALS OF THE RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM CORYNEBACTERIUM AMMONIAGENES
167, 4n83A, 0.5852, 2.93, 0.042, 285, 71, X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS SANGUINIS DIMANGANESE(II)- NRDF
168, 2wxkA, 0.5831, 3.25, 0.028, 835, 71, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH INK666.
169, 1oquD, 0.5831, 3.02, 0.056, 296, 72, A PROTEIN COORDINATED TRI-NUCLEAR FE COMPLEX FORMED DURING SOAKING OF CRYSTALS OF THE RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM CORYNEBACTERIUM AMMONIAGENES
170, 2wxgA, 0.5826, 3.25, 0.028, 835, 71, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW13.
171, 1oquB, 0.5816, 3.09, 0.056, 296, 72, A PROTEIN COORDINATED TRI-NUCLEAR FE COMPLEX FORMED DURING SOAKING OF CRYSTALS OF THE RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM CORYNEBACTERIUM AMMONIAGENES
172, 1kgpD, 0.5808, 3.08, 0.056, 296, 72, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS MN SUBSTITUTED FORM
173, 1oquA, 0.5802, 3.19, 0.068, 296, 73, A PROTEIN COORDINATED TRI-NUCLEAR FE COMPLEX FORMED DURING SOAKING OF CRYSTALS OF THE RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM CORYNEBACTERIUM AMMONIAGENES
174, 1kgpB, 0.5802, 3.18, 0.068, 296, 73, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS MN SUBSTITUTED FORM
175, 1kgnB, 0.5798, 3.17, 0.068, 296, 73, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS OXIDISED FE CONTAINING FORM
176, 1uzrA, 0.5797, 2.98, 0.056, 282, 71, CRYSTAL STRUCTURE OF THE CLASS IB RIBONUCLEOTIDE REDUCTASE R2F-2 SUBUNIT FROM MYCOBACTERIUM TUBERCULOSIS
177, 3dhzA, 0.5795, 3.03, 0.056, 295, 72, APO (IRON FREE) STRUCTURE OF C. AMMONIAGENES R2 PROTEIN
178, 1kgoD, 0.5794, 3.02, 0.056, 296, 72, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS REDUCED FE CONTAINING FORM
179, 1kgnD, 0.5793, 3.03, 0.056, 296, 72, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS OXIDISED FE CONTAINING FORM
180, 1kgpA, 0.5787, 3.18, 0.068, 296, 73, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS MN SUBSTITUTED FORM
181, 1kgoB, 0.5787, 3.19, 0.068, 296, 73, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS REDUCED FE CONTAINING FORM
182, 1kgnA, 0.5786, 3.18, 0.068, 296, 73, R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS OXIDISED FE CONTAINING FORM
183, 5gmyA, 0.5785, 3.17, 0.014, 848, 71, CRYSTAL STRUCTURE OF THE ARCHAEOGLOBUS FULGIDUS OLIGOSACCHARYLTRANSFERASE (O29867_ARCFU) TETHERED WITH AN ACCEPTOR PEPTIDE CONTAINING THE NVT SEQUON VIA A DISULFIDE BOND
184, 3dhzB, 0.5777, 3.14, 0.069, 296, 72, APO (IRON FREE) STRUCTURE OF C. AMMONIAGENES R2 PROTEIN
185, 3n3bB, 0.5752, 3.21, 0.069, 284, 72, RIBONUCLEOTIDE REDUCTASE DIMANGANESE(II)-NRDF FROM ESCHERICHIA COLI IN COMPLEX WITH REDUCED NRDI WITH A TRAPPED PEROXIDE
186, 3n37A, 0.5724, 3.10, 0.070, 284, 71, RIBONUCLEOTIDE REDUCTASE DIMANGANESE(II)-NRDF FROM ESCHERICHIA COLI
187, 5t23A, 0.5721, 2.93, 0.068, 804, 74, PI3KG IN COMPLEX WITH 5D
188, 3p2bA, 0.5719, 2.95, 0.054, 808, 74, CRYSTAL STRUCTURE OF PI3K GAMMA WITH 3-(2-MORPHOLINO-6-(PYRIDIN-3- YLAMINO)PYRIMIDIN-4-YL)PHENOL
189, 4wwpA, 0.5717, 2.95, 0.054, 820, 74, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH PYRIDINYLQUINOLINE INHIBITOR N-{(1S)-1-[8-CHLORO-2-(2-METHYLPYRIDIN- 3-YL)QUINOLIN-3-YL]ETHYL}-9H-PURIN-6-AMINE
190, 4dk5A, 0.5715, 2.96, 0.068, 834, 74, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL- TRIAZINE INHIBITOR
191, 4fjzA, 0.5711, 3.07, 0.053, 822, 75, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH PYRROLO-PYRIDINE INHIBITOR 63
192, 3s2aA, 0.5708, 3.07, 0.053, 834, 75, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH A QUINOLINE INHIBITOR
193, 4m1fA, 0.5705, 3.08, 0.070, 284, 71, X-RAY CRYSTAL STRUCTURE OF E. COLI APO NRDF
194, 4anwA, 0.5705, 2.99, 0.054, 833, 74, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
195, 5edsA, 0.5704, 2.94, 0.068, 823, 74, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH BENZIMIDAZOLE INHIBITOR 5
196, 3l08A, 0.5703, 3.13, 0.040, 828, 75, STRUCTURE OF PI3K GAMMA WITH A POTENT INHIBITOR: GSK2126458
197, 4anuA, 0.5701, 2.98, 0.041, 833, 74, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
198, 5luqA, 0.5698, 3.51, 0.043, 3615, 69, CRYSTAL STRUCTURE OF HUMAN DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (DNA-PKCS)
199, 3preA, 0.5698, 2.96, 0.054, 839, 74, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
200, 3l54A, 0.5695, 2.99, 0.054, 837, 74, STRUCTURE OF PI3K GAMMA WITH INHIBITOR
201, 4hleA, 0.5687, 2.95, 0.054, 828, 74, COMPOUND 21 (1-ALKYL-SUBSTITUTED 124-TRIAZOLES)
202, 3qarA, 0.5687, 2.94, 0.054, 834, 74, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 32
203, 4urkA, 0.5686, 2.96, 0.054, 837, 74, PI3KG IN COMPLEX WITH AZD6482
204, 3eneA, 0.5686, 3.00, 0.054, 843, 74, COMPLEX OF PI3K GAMMA WITH AN INHIBITOR
205, 4kzcA, 0.5685, 2.94, 0.054, 821, 74, STRUCTURE OF PI3K GAMMA WITH IMIDAZOPYRIDINE INHIBITORS
206, 2chzA, 0.5685, 2.94, 0.068, 839, 74, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-93
207, 4wwnA, 0.5684, 2.97, 0.054, 831, 74, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH (S)-N-(1-(7- FLUORO-2-(PYRIDIN-2-YL)QUINOLIN-3-YL)ETHYL)-9H-PURIN-6-AMINE AMG319 INHIBITOR
208, 4fjyA, 0.5682, 3.00, 0.054, 839, 74, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH QUINOLINE-INDOLINE INHIBITOR 24F
209, 3apfA, 0.5681, 3.06, 0.053, 840, 75, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5039699
210, 3apdA, 0.5681, 2.97, 0.054, 839, 74, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5108134
211, 4anvA, 0.5680, 3.01, 0.041, 848, 74, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
212, 3tjpA, 0.5680, 2.97, 0.054, 840, 74, CRYSTAL STRUCTURE OF PI3K GAMMA WITH N6-(34-DIMETHOXYPHENYL)-2- MORPHOLINO-[45 -BIPYRIMIDINE]-2 6-DIAMINE
213, 4wwoA, 0.5679, 2.96, 0.054, 814, 74, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH PHENYLQUINOLINE INHIBITOR N-{(1S)-1-[8-CHLORO-2-(3-FLUOROPHENYL)QUINOLIN-3-YL]ETHYL}- 9H-PURIN-6-AMINE
214, 3dbsA, 0.5677, 3.10, 0.053, 841, 75, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH GDC0941
215, 4flhA, 0.5675, 3.10, 0.053, 840, 75, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH AMG511
216, 2x6jA, 0.5675, 3.26, 0.099, 545, 71, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34 IN COMPLEX WITH PIK-93
217, 1e90A, 0.5675, 2.99, 0.054, 844, 74, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
218, 6emgB, 0.5674, 3.16, 0.085, 226, 71, CRYSTAL STRUCTURE OF RRP1 FROM CHAETOMIUM THERMOPHILUM IN SPACE GROUP P6322
219, 6emfA, 0.5674, 3.16, 0.085, 228, 71, CRYSTAL STRUCTURE OF RRP1 FROM CHAETOMIUM THERMOPHILUM IN SPACE GROUP C2
220, 3r7rA, 0.5673, 2.99, 0.054, 838, 74, STRUCTURE-BASED DESIGN OF THIENOBENZOXEPIN INHIBITORS OF PI3-KINASE
221, 5kaeA, 0.5672, 2.99, 0.054, 840, 74, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH QUINOLINE- CONTAINING INHIBITOR 5G
222, 3t8mA, 0.5672, 2.99, 0.054, 841, 74, RATIONAL DESIGN OF PI3K-ALPHA INHIBITORS THAT EXHIBIT SELECTIVITY OVER THE PI3K-BETA ISOFORM
223, 4xx5A, 0.5670, 2.96, 0.054, 843, 74, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH AN INHIBITOR
224, 3apcA, 0.5669, 2.98, 0.054, 839, 74, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5132799
225, 2chwA, 0.5669, 3.09, 0.040, 840, 75, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110 ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-39
226, 3nzsA, 0.5668, 2.99, 0.041, 828, 74, STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE
227, 2chxA, 0.5668, 2.99, 0.041, 842, 74, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90
228, 3lj3A, 0.5666, 3.02, 0.054, 829, 74, PI3-KINASE-GAMMA WITH A PYRROLOPYRIDINE-BENZOFURAN INHIBITOR
229, 1he8A, 0.5665, 3.00, 0.054, 749, 74, RAS G12V - PI 3-KINASE GAMMA COMPLEX
230, 4anxA, 0.5663, 3.00, 0.041, 833, 74, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
231, 3qk0A, 0.5663, 2.97, 0.054, 820, 74, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH BENZOTHIAZOLE 82
232, 3ibeA, 0.5661, 2.98, 0.068, 850, 74, CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR BOUND TO PI3 KINASE GAMMA
233, 5jhaA, 0.5659, 2.99, 0.041, 803, 74, STRUCTURE OF PHOSPHOINOSITIDE 3-KINASE GAMMA (PI3K) BOUND TO THE POTENT INHIBITOR PIKIN2
234, 1e7uA, 0.5659, 3.01, 0.054, 872, 74, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
235, 4f1sA, 0.5657, 3.02, 0.054, 834, 74, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL- TRIAZINE-SULFONAMIDE INHIBITOR
236, 3mjwA, 0.5657, 3.00, 0.041, 819, 74, PI3 KINASE GAMMA WITH A BENZOFURANONE INHIBITOR
237, 2a4zA, 0.5653, 3.10, 0.053, 812, 75, CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS604850
238, 4kz0A, 0.5651, 2.99, 0.054, 833, 74, STRUCTURE OF PI3K GAMMA WITH IMIDAZOPYRIDINE INHIBITORS
239, 5g2nA, 0.5649, 3.01, 0.054, 823, 74, X-RAY STRUCTURE OF PI3KINASE GAMMA IN COMPLEX WITH COPANLISIB
240, 3ml8A, 0.5649, 2.97, 0.054, 843, 74, DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN
241, 3r7qA, 0.5648, 3.00, 0.054, 837, 74, STRUCTURE-BASED DESIGN OF THIENOBENZOXEPIN INHIBITORS OF PI3- KINASE
242, 4fa6A, 0.5647, 3.00, 0.041, 842, 74, DESIGN AND SYNTHESIS OF A NOVEL PYRROLIDINYL PYRIDO PYRIMIDINONE DERIVATIVE AS A POTENT INHIBITOR OF PI3KA AND MTOR
243, 3zvvA, 0.5647, 3.00, 0.054, 829, 74, FRAGMENT BOUND TO PI3KINASE GAMMA
244, 3cstA, 0.5647, 2.93, 0.054, 836, 74, CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR E5E2
245, 6c1sA, 0.5645, 3.09, 0.040, 826, 75, PHOSPHOINOSITIDE 3-KINASE GAMMA BOUND TO AN PYRROLOPYRIDINONE INHIBITOR 
246, 4hvbA, 0.5645, 3.00, 0.054, 830, 74, CATALYTIC UNIT OF PI3KG IN COMPLEX WITH PI3K/MTOR DUAL INHIBITOR PF- 04979064
247, 1e8wA, 0.5645, 3.12, 0.040, 851, 75, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
248, 3csfA, 0.5644, 2.94, 0.054, 839, 74, CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR DW2
249, 3przA, 0.5639, 2.95, 0.054, 844, 74, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
250, 3ps6A, 0.5638, 3.00, 0.041, 841, 74, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
251, 3n3bA, 0.5636, 3.18, 0.069, 284, 72, RIBONUCLEOTIDE REDUCTASE DIMANGANESE(II)-NRDF FROM ESCHERICHIA COLI IN COMPLEX WITH REDUCED NRDI WITH A TRAPPED PEROXIDE
252, 3l13A, 0.5634, 2.98, 0.054, 841, 74, CRYSTAL STRUCTURES OF PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS
253, 2a5uA, 0.5634, 3.09, 0.040, 839, 75, CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS605240
254, 3n39A, 0.5633, 3.10, 0.070, 282, 71, RIBONUCLEOTIDE REDUCTASE DIMANGANESE(II)-NRDF FROM ESCHERICHIA COLI IN COMPLEX WITH NRDI
255, 4fadA, 0.5632, 2.97, 0.054, 839, 74, DESIGN AND SYNTHESIS OF A NOVEL PYRROLIDINYL PYRIDO PYRIMIDINONE DERIVATIVE AS A POTENT INHIBITOR OF PI3KA AND MTOR
256, 3zw3A, 0.5624, 2.97, 0.054, 831, 74, FRAGMENT BASED DISCOVERY OF A NOVEL AND SELECTIVE PI3 KINASE INHIBITOR
257, 2x6iA, 0.5620, 3.31, 0.099, 546, 71, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34 IN COMPLEX WITH PIK-90
258, 2x6hA, 0.5615, 3.31, 0.099, 543, 71, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34
259, 3dpdA, 0.5613, 3.02, 0.041, 846, 74, ACHIEVING MULTI-ISOFORM PI3K INHIBITION IN A SERIES OF SUBSTITUTED 34-DIHYDRO-2H-BENZO[14]OXAZINES
260, 3l17A, 0.5611, 2.96, 0.054, 841, 74, DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT SELECTIVE AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3- KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER
261, 1fz2A, 0.5601, 3.01, 0.058, 511, 69, METHANE MONOOXYGENASE HYDROXYLASE FORM II MIXED-VALENT GENERATED BY CRYSTAL SOAKING
262, 5sxkA, 0.5598, 3.46, 0.053, 1053, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 18
263, 2x6fA, 0.5598, 3.46, 0.097, 543, 72, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34 IN COMPLEX WITH 3-METHYLADENINE
264, 1fz4A, 0.5594, 3.45, 0.056, 511, 71, METHANE MONOOXYGENASE HYDROXYLASE FORM III SOAKED AT PH 8.5 (0.1 M TRIS)
265, 4gamA, 0.5592, 3.36, 0.085, 511, 71, COMPLEX STRUCTURE OF METHANE MONOOXYGENASE HYDROXYLASE AND REGULATORY SUBUNIT
266, 5sxeA, 0.5586, 3.46, 0.053, 1046, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 19 AND 28
267, 4gamF, 0.5580, 3.39, 0.099, 511, 71, COMPLEX STRUCTURE OF METHANE MONOOXYGENASE HYDROXYLASE AND REGULATORY SUBUNIT
268, 5sx9A, 0.5579, 3.46, 0.053, 1044, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 14
269, 5sx8A, 0.5576, 3.48, 0.053, 1052, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 12 AND 15
270, 5ngbA, 0.5575, 3.16, 0.068, 816, 74, X-RAY DIFFRACTION CRYSTAL STRUCTURE OF THE MURINE PI3K P110DELTA IN COMPLEX WITH A PAN INHIBITOR
271, 5t8iA, 0.5574, 3.14, 0.068, 808, 74, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-9901
272, 4v0iA, 0.5573, 3.17, 0.068, 759, 74, WATER NETWORK DETERMINES SELECTIVITY FOR A SERIES OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS OVER PI3K-DELTA
273, 1fyzA, 0.5573, 3.46, 0.056, 511, 71, METHANE MONOOXYGENASE HYDROXYLASE FORM II REDUCED BY SOAKING
274, 1fz9A, 0.5568, 3.46, 0.056, 511, 71, METHANE MONOOXYGENASE HYDROXYLASE FORM II COCRYSTALLIZED WITH IODOETHANE
275, 4v0iB, 0.5566, 3.17, 0.068, 792, 74, WATER NETWORK DETERMINES SELECTIVITY FOR A SERIES OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS OVER PI3K-DELTA
276, 1xmhB, 0.5566, 3.41, 0.086, 511, 70, STRUCTURE OF CO(II) RECONSTITUTED METHANE MONOOXYGENASE HYDROXYLASE FROM M. CAPSULATUS (BATH)
277, 5sxiA, 0.5564, 3.48, 0.039, 1040, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 13
278, 1fz5A, 0.5564, 3.51, 0.099, 511, 71, METHANE MONOOXYGENASE HYDROXYLASE FORM II CRYSTALLIZED ANAEROBICALLY FROM REDUCED ENZYME
279, 1fyzB, 0.5564, 3.38, 0.086, 511, 70, METHANE MONOOXYGENASE HYDROXYLASE FORM II REDUCED BY SOAKING
280, 5xghA, 0.5563, 3.32, 0.053, 993, 75, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
281, 4gamK, 0.5563, 3.37, 0.085, 511, 71, COMPLEX STRUCTURE OF METHANE MONOOXYGENASE HYDROXYLASE AND REGULATORY SUBUNIT
282, 5dxtA, 0.5562, 3.49, 0.053, 879, 76, P110ALPHA WITH GDC-0326
283, 5sxfA, 0.5560, 3.45, 0.053, 1023, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 9
284, 4gamP, 0.5560, 3.39, 0.085, 511, 71, COMPLEX STRUCTURE OF METHANE MONOOXYGENASE HYDROXYLASE AND REGULATORY SUBUNIT
285, 2x6kB, 0.5559, 3.72, 0.067, 550, 75, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34 IN COMPLEX WITH PI-103
286, 1fz1A, 0.5558, 3.38, 0.086, 511, 70, METHANE MONOOXYGENASE HYDROXYLASE FORM III OXIDIZED
287, 5luqB, 0.5557, 3.42, 0.044, 3615, 68, CRYSTAL STRUCTURE OF HUMAN DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (DNA-PKCS)
288, 1mmoD, 0.5557, 3.23, 0.101, 512, 69, CRYSTAL STRUCTURE OF A BACTERIAL NON-HAEM IRON HYDROXYLASE THAT CATALYSES THE BIOLOGICAL OXIDATION OF METHANE
289, 1fzhA, 0.5557, 3.47, 0.056, 511, 71, METHANE MONOOXYGENASE HYDROXYLASE FORM II PRESSURIZED WITH XENON GAS
290, 5t7fA, 0.5555, 3.14, 0.068, 819, 74, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-643624
291, 1fz3A, 0.5555, 3.38, 0.086, 511, 70, METHANE MONOOXYGENASE HYDROXYLASE FORM III SOAK AT PH 6.2 (0.1 M PIPES)
292, 4a55A, 0.5552, 3.13, 0.081, 1001, 74, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH ISH2 OF P85ALPHA AND THE INHIBITOR PIK-108
293, 4bfrB, 0.5550, 3.18, 0.055, 836, 73, DISCOVERY AND OPTIMIZATION OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
294, 5sxjA, 0.5549, 3.48, 0.053, 1039, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 29
295, 5sxdA, 0.5549, 3.51, 0.039, 1049, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 22
296, 5swtA, 0.5549, 3.48, 0.053, 1057, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 17 AND 27
297, 5fi4A, 0.5548, 3.48, 0.039, 1009, 76, DISCOVERY OF IMIDAZO[12-A]-PYRIDINE INHIBITORS OF PAN-PI3 KINASES THAT ARE EFFICACIOUS IN A MOUSE XENOGRAFT MODEL
298, 5xgjA, 0.5546, 3.45, 0.053, 980, 76, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
299, 4ajwB, 0.5546, 3.18, 0.068, 792, 74, DISCOVERY AND OPTIMIZATION OF NEW BENZIMIDAZOLE- AND BENZOXAZOLE- PYRIMIDONE SELECTIVE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
300, 3hhmA, 0.5546, 3.48, 0.053, 1032, 76, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA AND THE DRUG WORTMANNIN
301, 5sxcA, 0.5545, 3.49, 0.053, 1038, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 8
302, 5dxhA, 0.5545, 3.47, 0.053, 989, 76, P110ALPHA/P85ALPHA WITH COMPOUND 5
303, 5xgiA, 0.5544, 3.46, 0.053, 1013, 76, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
304, 5swpA, 0.5544, 3.34, 0.053, 1058, 75, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 6 AND 24
305, 6dgtA, 0.5543, 3.15, 0.068, 777, 74, SELECTIVE PI3K BETA INHIBITOR BOUND TO PI3K DELTA 
306, 5ubrA, 0.5543, 3.50, 0.053, 887, 76, CRYSTAL STRUCTURE OF PI3K ALPHA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1- YL)PHENYL)PYRROLO[21-F][124] TRIAZIN-4-AMINE DERIVIATINE
307, 5swrA, 0.5542, 3.48, 0.053, 1051, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 20 AND 26
308, 1mtyD, 0.5542, 3.43, 0.099, 512, 71, METHANE MONOOXYGENASE HYDROXYLASE FROM METHYLOCOCCUS CAPSULATUS (BATH)
309, 1fziA, 0.5542, 3.43, 0.099, 512, 71, METHANE MONOOXYGENASE HYDROXYLASE FORM I PRESSURIZED WITH XENON GAS
310, 5t7fB, 0.5541, 3.17, 0.068, 816, 74, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-643624
311, 4ovvA, 0.5541, 3.46, 0.039, 1042, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH DIC4-PIP2
312, 5t2lA, 0.5540, 3.17, 0.068, 830, 74, MPI3KD IN COMPLEX WITH 7L
313, 3zimA, 0.5540, 3.36, 0.053, 886, 75, DISCOVERY OF A POTENT AND ISOFORM-SELECTIVE TARGETED COVALENT INHIBITOR OF THE LIPID KINASE PI3KALPHA
314, 1fz8A, 0.5539, 3.51, 0.099, 511, 71, METHANE MONOOXYGENASE HYDROXYLASE FORM II COCRYSTALLIZED WITH DIBROMOMETHANE
315, 4l2yA, 0.5537, 3.44, 0.053, 991, 76, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND COMPOUND 9D
316, 1xvcA, 0.5537, 3.24, 0.101, 511, 69, SOLUBLE METHANE MONOOXYGENASE HYDROXYLASE: 8-BROMOOCTANOL SOAKED STRUCTURE
317, 5dxhD, 0.5536, 3.46, 0.053, 981, 76, P110ALPHA/P85ALPHA WITH COMPOUND 5
318, 4ajwA, 0.5534, 3.17, 0.068, 765, 74, DISCOVERY AND OPTIMIZATION OF NEW BENZIMIDAZOLE- AND BENZOXAZOLE- PYRIMIDONE SELECTIVE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
319, 1fz1B, 0.5531, 3.25, 0.101, 511, 69, METHANE MONOOXYGENASE HYDROXYLASE FORM III OXIDIZED
320, 5sw8A, 0.5529, 3.49, 0.039, 1030, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 7 AND 11
321, 5sxaA, 0.5528, 3.41, 0.066, 1049, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 10
322, 5o83A, 0.5528, 3.18, 0.068, 794, 74, DISCOVERY OF CDZ173 (LENIOLISIB) REPRESENTING A STRUCTURALLY NOVEL CLASS OF PI3K DELTA-SELECTIVE INHIBITORS
323, 4yknA, 0.5528, 3.44, 0.053, 1205, 76, PI3K ALPHA LIPID KINASE WITH ACTIVE SITE INHIBITOR
324, 1mmoE, 0.5527, 3.26, 0.101, 512, 69, CRYSTAL STRUCTURE OF A BACTERIAL NON-HAEM IRON HYDROXYLASE THAT CATALYSES THE BIOLOGICAL OXIDATION OF METHANE
325, 5sxbA, 0.5526, 3.52, 0.053, 1056, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 23
326, 2wxrA, 0.5525, 3.19, 0.068, 822, 74, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA.
327, 5swoA, 0.5524, 3.51, 0.039, 1050, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 4 AND 19
328, 5swgA, 0.5523, 3.48, 0.053, 1041, 76, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 5 AND 21
329, 2wxoA, 0.5523, 3.18, 0.068, 822, 74, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH AS5.
330, 1fz0B, 0.5521, 3.25, 0.101, 511, 69, METHANE MONOOXYGENASE HYDROXYLASE FORM II MIXED-VALENT GROWN ANAEROBICALLY
331, 1mtyE, 0.5520, 3.26, 0.101, 512, 69, METHANE MONOOXYGENASE HYDROXYLASE FROM METHYLOCOCCUS CAPSULATUS (BATH)
332, 1fziB, 0.5520, 3.26, 0.101, 512, 69, METHANE MONOOXYGENASE HYDROXYLASE FORM I PRESSURIZED WITH XENON GAS
333, 5i4uA, 0.5519, 3.18, 0.068, 815, 74, THE CRYSTAL STRUCTURE OF PI3KDELTA WITH COMPOUND 34
334, 5m6uA, 0.5518, 3.05, 0.068, 916, 73, HUMAN PI3KDELTA IN COMPLEX WITH LASW1579
335, 1fz0A, 0.5518, 3.26, 0.101, 511, 69, METHANE MONOOXYGENASE HYDROXYLASE FORM II MIXED-VALENT GROWN ANAEROBICALLY
336, 4wafA, 0.5517, 3.51, 0.053, 1017, 76, CRYSTAL STRUCTURE OF A NOVEL TETRAHYDROPYRAZOLO[15-A]PYRAZINE IN AN ENGINEERED PI3K ALPHA
337, 5t28A, 0.5515, 3.18, 0.068, 822, 74, MPI3KD IN COMPLEX WITH 5K
338, 2x6hB, 0.5512, 3.33, 0.071, 543, 70, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34
339, 1fz3B, 0.5512, 3.26, 0.101, 511, 69, METHANE MONOOXYGENASE HYDROXYLASE FORM III SOAK AT PH 6.2 (0.1 M PIPES)
340, 5ul1A, 0.5511, 3.23, 0.054, 1000, 74, THE CO-STRUCTURE OF 3-AMINO-6-(4-((1-(DIMETHYLAMINO)PROPAN-2-YL) SULFONYL)PHENYL)-N-PHENYLPYRAZINE-2-CARBOXAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
341, 5ae8A, 0.5511, 3.20, 0.068, 856, 74, CRYSTAL STRUCTURE OF MOUSE PI3 KINASE DELTA IN COMPLEX WITH GSK2269557
342, 2rd0A, 0.5511, 3.25, 0.054, 997, 74, STRUCTURE OF A HUMAN P110ALPHA/P85ALPHA COMPLEX
343, 5t2iA, 0.5509, 3.17, 0.068, 820, 74, MPI3KD IN COMPLEX WITH 7K
344, 4xe0A, 0.5507, 3.20, 0.068, 815, 74, IDELALISIB BOUND TO THE P110 SUBUNIT OF PI3K DELTA
345, 5ubtA, 0.5506, 3.09, 0.068, 911, 73, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1- YL)PHENYL)PYRROLO[21-F][124] TRIAZIN-4-AMINE DERIVIATINE
346, 5t27A, 0.5506, 3.19, 0.068, 819, 74, MPI3KD IN COMPLEX WITH 5D
347, 5t2mA, 0.5503, 3.19, 0.068, 820, 74, MPI3KD IN COMPLEX WITH 7M
348, 5ukjA, 0.5502, 3.24, 0.054, 1009, 74, THE CO-STRUCTURE OF NN-DIMETHYL-4-[(6R)-6-METHYL-5-(1H-PYRROLO[23- B]PYRIDIN-4-YL)-4567-TETRAHYDROPYRAZOLO[15- A]PYRAZIN-3- YL]BENZENESULFONAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
349, 2wxpA, 0.5501, 3.19, 0.068, 822, 74, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH GDC-0941.
350, 5t2gA, 0.5499, 3.19, 0.068, 820, 74, MPI3KD IN COMPLEX WITH 7I
351, 5dxuA, 0.5499, 3.11, 0.068, 922, 73, P110DELTA/P85ALPHA WITH GDC-0326
352, 5t2dA, 0.5498, 3.19, 0.068, 820, 74, MPI3KD IN COMPLEX WITH 7J
353, 5i6uA, 0.5498, 3.20, 0.068, 816, 74, THE CRYSTAL STRUCTURE OF PI3KDELTA WITH COMPOUND 32
354, 6ftnA, 0.5496, 3.20, 0.068, 827, 74, MPI3KD IN COMPLEX WITH AZ2 
355, 2y3aA, 0.5496, 3.24, 0.055, 976, 73, CRYSTAL STRUCTURE OF P110BETA IN COMPLEX WITH ICSH2 OF P85BETA AND THE DRUG GDC-0941
356, 3rceA, 0.5494, 3.84, 0.042, 683, 72, BACTERIAL OLIGOSACCHARYLTRANSFERASE PGLB
357, 2x6jB, 0.5491, 3.48, 0.099, 546, 71, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34 IN COMPLEX WITH PIK-93
358, 5t8fA, 0.5490, 3.10, 0.068, 921, 73, P110DELTA/P85ALPHA WITH TASELISIB (GDC-0032)
359, 2wxnA, 0.5490, 3.21, 0.068, 822, 74, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH DL07.
360, 5is5A, 0.5487, 3.21, 0.068, 785, 74, DISCOVERY AND PHARMACOLOGICAL CHARACTERIZATION OF NOVEL QUINAZOLINE- BASED PI3K DELTA-SELECTIVE INHIBITORS
361, 4l23A, 0.5486, 3.42, 0.053, 1014, 76, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND PI-103
362, 1mhyD, 0.5486, 3.39, 0.114, 510, 70, METHANE MONOOXYGENASE HYDROXYLASE
363, 5itdA, 0.5484, 3.53, 0.053, 995, 76, CRYSTAL STRUCTURE OF PI3K ALPHA WITH PI3K DELTA INHIBITOR
364, 6ez6A, 0.5483, 3.21, 0.068, 863, 74, PI3 KINASE DELTA IN COMPLEX WITH METHYL 5-(4-(5-((4- ISOPROPYLPIPERAZIN-1-YL)METHYL)OXAZOL-2-YL)-1H-INDAZOL-6-YL)-2- METHOXYNICOTINATE
365, 4bfrA, 0.5479, 3.36, 0.055, 855, 73, DISCOVERY AND OPTIMIZATION OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
366, 2wxhA, 0.5479, 3.21, 0.068, 822, 74, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW14.
367, 2wxlA, 0.5477, 3.32, 0.067, 823, 75, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH ZSTK474.
368, 2wxmA, 0.5476, 3.21, 0.068, 822, 74, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH DL06.
369, 5vlrA, 0.5475, 3.11, 0.068, 926, 73, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A TRIFLUORO-ETHYL- PYRAZOL-PYROLOTRIAZINE INHIBITOR
370, 2wxqA, 0.5475, 3.31, 0.067, 822, 75, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH AS15.
371, 5t2bA, 0.5474, 3.22, 0.068, 820, 74, MPI3KD IN COMPLEX WITH 5E
372, 2x38A, 0.5474, 3.32, 0.067, 822, 75, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH IC87114.
373, 5l72A, 0.5471, 3.09, 0.068, 858, 73, PI3 KINASE DELTA IN COMPLEX WITH N-[6-(5-METHANESULFONAMIDO-6- METHOXYPYRIDIN-3-YL)-13-DIHYDRO-2-BENZOFURAN-4-YL]-2-(MORPHOLIN-4- YL)ACETAMIDE
374, 2wxiA, 0.5470, 3.16, 0.068, 815, 74, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW30.
375, 2wxfA, 0.5470, 3.21, 0.068, 822, 74, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH PIK-39.
376, 5ae9A, 0.5466, 3.22, 0.068, 858, 74, CRYSTAL STRUCTURE OF MOUSE PI3 KINASE DELTA IN COMPLEX WITH GSK2292767
377, 5ncyA, 0.5465, 3.22, 0.068, 827, 74, MPI3KD IN COMPLEX WITH INH1
378, 2wxjA, 0.5462, 3.23, 0.068, 822, 74, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH INK654.
379, 5nczA, 0.5459, 3.21, 0.068, 827, 74, MPI3KD IN COMPLEX WITH INH1
380, 1mhzD, 0.5457, 3.42, 0.114, 510, 70, METHANE MONOOXYGENASE HYDROXYLASE
381, 6eyzA, 0.5454, 3.34, 0.067, 862, 75, PI3 KINASE DELTA IN COMPLEX WITH 4-FLUOROPHENYL 5-(4-(5-((4- ISOPROPYLPIPERAZIN-1-YL)METHYL)OXAZOL-2-YL)-1H-INDAZOL-6-YL)-2- METHOXYNICOTINATE
382, 3wakA, 0.5453, 3.02, 0.014, 864, 69, CRYSTAL STRUCTURE OF THE ARCHAEOGLOBUS FULGIDUS OLIGOSACCHARYLTRANSFERASE (O29867_ARCFU) IN THE APO FORM
383, 5np1A, 0.5442, 3.41, 0.030, 2460, 67, OPEN PROTOMER OF HUMAN ATM (ATAXIA TELANGIECTASIA MUTATED)
384, 2x6iB, 0.5433, 3.49, 0.099, 544, 71, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34 IN COMPLEX WITH PIK-90
385, 5y3rC, 0.5427, 3.29, 0.075, 3636, 67, CRYO-EM STRUCTURE OF HUMAN DNA-PK HOLOENZYME
386, 2x6fB, 0.5406, 4.00, 0.027, 542, 73, THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34 IN COMPLEX WITH 3-METHYLADENINE
387, 5kc2C, 0.5401, 3.65, 0.132, 783, 68, NEGATIVE STAIN STRUCTURE OF VPS15/VPS34 COMPLEX
388, 5dfzC, 0.5401, 3.65, 0.132, 783, 68, STRUCTURE OF VPS34 COMPLEX II FROM S. CEREVISIAE.
389, 2r2fA, 0.5326, 3.33, 0.031, 286, 64, RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM SALMONELLA TYPHIMURIUM (OXIDIZED)
390, 5oglA, 0.5284, 3.50, 0.056, 707, 71, STRUCTURE OF BACTERIAL OLIGOSACCHARYLTRANSFERASE PGLB IN COMPLEX WITH AN ACCEPTOR PEPTIDE AND AN LIPID-LINKED OLIGOSACCHARIDE ANALOG
391, 5w1rA, 0.5278, 3.45, 0.059, 3563, 68, CRYO-EM STRUCTURE OF DNAPKCS
392, 1uzrB, 0.5278, 3.30, 0.031, 288, 64, CRYSTAL STRUCTURE OF THE CLASS IB RIBONUCLEOTIDE REDUCTASE R2F-2 SUBUNIT FROM MYCOBACTERIUM TUBERCULOSIS
393, 1uzrC, 0.5267, 3.33, 0.031, 283, 64, CRYSTAL STRUCTURE OF THE CLASS IB RIBONUCLEOTIDE REDUCTASE R2F-2 SUBUNIT FROM MYCOBACTERIUM TUBERCULOSIS
394, 5fbvA, 0.5242, 3.63, 0.000, 465, 70, PI4KB IN COMPLEX WITH RAB11 AND THE MI364 INHIBITOR
395, 2r2fB, 0.5240, 3.34, 0.031, 285, 64, RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM SALMONELLA TYPHIMURIUM (OXIDIZED)
396, 5fblA, 0.5225, 3.83, 0.014, 465, 71, PI4KB IN COMPLEX WITH RAB11 AND THE MI356 INHIBITOR
397, 5fbrA, 0.5221, 3.63, 0.029, 465, 70, PI4KB IN COMPLEX WITH RAB11 AND THE MI359 INHIBITOR
398, 5fbqA, 0.5218, 3.73, 0.029, 467, 70, PI4KB IN COMPLEX WITH RAB11 AND THE MI358 INHIBITOR
399, 5yz0B, 0.5215, 3.77, 0.055, 2362, 73, CRYO-EM STRUCTURE OF HUMAN ATR-ATRIP COMPLEX
400, 4d0lA, 0.5210, 3.63, 0.029, 470, 70, PHOSPHATIDYLINOSITOL 4-KINASE III BETA-PIK93 IN A COMPLEX WITH RAB11A-GTP GAMMAS
401, 5euqE, 0.5181, 3.89, 0.028, 464, 72, CRYSTAL STRUCTURE OF AN ENGINEERED CONSTRUCT OF PHOSPHATIDYLINOSITOL 4 KINASE III BETA WITH A POTENT AND SELECTIVE INHIBITOR IN COMPLEX WITH GDP LOADED RAB11
402, 5ojsT, 0.5176, 3.93, 0.029, 3473, 68, CRYO-EM STRUCTURE OF THE SAGA AND NUA4 COACTIVATOR SUBUNIT TRA1
403, 5fbwA, 0.5174, 3.67, 0.014, 463, 70, PI4KB IN COMPLEX WITH RAB11 AND THE MI369 INHIBITOR
404, 3n3aB, 0.5171, 3.30, 0.032, 282, 63, RIBONUCLEOTIDE REDUCTASE DIMANGANESE(II)-NRDF FROM ESCHERICHIA COLI IN COMPLEX WITH REDUCED NRDI
405, 4waeA, 0.5166, 3.63, 0.000, 463, 70, PHOSPHATIDYLINOSITOL 4-KINASE III BETA CRYSTALLIZED WITH ATP
406, 2bq1J, 0.5165, 3.38, 0.031, 281, 64, RIBONUCLEOTIDE REDUCTASE CLASS 1B HOLOCOMPLEX R1ER2F FROM SALMONELLA TYPHIMURIUM
407, 1r2fA, 0.5165, 3.41, 0.031, 283, 64, RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM SALMONELLA TYPHIMURIUM
408, 1r2fB, 0.5163, 3.42, 0.031, 281, 64, RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM SALMONELLA TYPHIMURIUM
409, 3n38A, 0.5160, 3.40, 0.031, 282, 64, RIBONUCLEOTIDE REDUCTASE NRDF FROM ESCHERICHIA COLI SOAKED WITH FERROUS IONS
410, 5t8fB, 0.5154, 2.96, 0.035, 169, 57, P110DELTA/P85ALPHA WITH TASELISIB (GDC-0032)
411, 3n3aA, 0.5149, 3.40, 0.031, 282, 64, RIBONUCLEOTIDE REDUCTASE DIMANGANESE(II)-NRDF FROM ESCHERICHIA COLI IN COMPLEX WITH REDUCED NRDI
412, 5dxuB, 0.5147, 2.99, 0.035, 169, 57, P110DELTA/P85ALPHA WITH GDC-0326
413, 4d0lE, 0.5147, 3.86, 0.028, 479, 71, PHOSPHATIDYLINOSITOL 4-KINASE III BETA-PIK93 IN A COMPLEX WITH RAB11A-GTP GAMMAS
414, 3n39B, 0.5139, 3.40, 0.031, 282, 64, RIBONUCLEOTIDE REDUCTASE DIMANGANESE(II)-NRDF FROM ESCHERICHIA COLI IN COMPLEX WITH NRDI
415, 4ovuB, 0.5136, 3.48, 0.032, 268, 62, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH NISH2 OF P85ALPHA
416, 5wbuA, 0.5117, 3.93, 0.055, 1052, 73, CRYSTAL STRUCTURE OF MTOR(DELTAN)-MLST8-PRAS40(ALPHA-HELIX & BETA- STRAND) COMPLEX
417, 5vlrB, 0.5117, 3.19, 0.034, 170, 58, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A TRIFLUORO-ETHYL- PYRAZOL-PYROLOTRIAZINE INHIBITOR
418, 6emkA, 0.5104, 3.73, 0.028, 2262, 72, CRYO-EM STRUCTURE OF SACCHAROMYCES CEREVISIAE TARGET OF RAPAMYCIN COMPLEX 2
419, 4jt5A, 0.5102, 3.94, 0.055, 1054, 73, MTORDELTAN-MLST8-PP242 COMPLEX
420, 4jsxA, 0.5102, 3.95, 0.055, 1054, 73, STRUCTURE OF MTORDELTAN-MLST8-TORIN2 COMPLEX
421, 5y81A, 0.5094, 3.51, 0.015, 2007, 65, NUA4 TEEAA SUB-COMPLEX 
422, 5wbyA, 0.5085, 3.95, 0.055, 1052, 73, CRYSTAL STRUCTURE OF MTOR(DELTAN)-MLST8-PRAS40(BETA-STRAND) COMPLEX
423, 5swpB, 0.5081, 3.37, 0.033, 258, 60, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 6 AND 24
424, 5yz0A, 0.5080, 3.54, 0.043, 2362, 70, CRYO-EM STRUCTURE OF HUMAN ATR-ATRIP COMPLEX
425, 4jsnA, 0.5078, 3.95, 0.055, 1054, 73, STRUCTURE OF MTORDELTAN-MLST8 COMPLEX
426, 4n83F, 0.5077, 3.53, 0.062, 284, 64, X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS SANGUINIS DIMANGANESE(II)- NRDF
427, 4jt6A, 0.5069, 3.96, 0.055, 1054, 73, STRUCTURE OF MTORDELTAN-MLST8-PI-103 COMPLEX
428, 6bcxE, 0.5056, 3.86, 0.055, 2178, 73, struct.pdbx_descriptor              
429, 6bcxA, 0.5056, 3.86, 0.055, 2178, 73, struct.pdbx_descriptor              
430, 4n83E, 0.5049, 3.42, 0.048, 284, 62, X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS SANGUINIS DIMANGANESE(II)- NRDF
431, 4n83C, 0.5041, 3.61, 0.047, 284, 64, X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS SANGUINIS DIMANGANESE(II)- NRDF
432, 5ubtB, 0.5026, 2.85, 0.037, 163, 54, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1- YL)PHENYL)PYRROLO[21-F][124] TRIAZIN-4-AMINE DERIVIATINE
433, 5sx9B, 0.5024, 3.29, 0.034, 239, 58, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 14
434, 4n83B, 0.5022, 3.54, 0.048, 284, 63, X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS SANGUINIS DIMANGANESE(II)- NRDF
435, 4n83D, 0.5006, 3.49, 0.048, 284, 63, X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS SANGUINIS DIMANGANESE(II)- NRDF
